Matthew Freer serves as the Senior Business Development Manager at RoukenBio, where responsibilities involve facilitating access to advanced solutions in drug development, particularly in immunology and preclinical safety assessment. As the Founder and CEO of Oakhouse Scientific, Freer specializes in driving growth and operational excellence within the biotech sector. Additionally, Freer acts as a Business Development Consultant for both LABSKIN LIMITED and ImmuONE, focusing on in vitro cell culture products and services. A member of the Scientific Advisory Board for FRAME, Freer contributes expertise in advancing non-animal testing alternatives. Previous roles include Business Development and Fundraising Manager at TREAT-NMD and Senior Business Development Manager at Alcyomics. Freer has extensive experience in research, having held positions at Durham University, and has a PhD in Tissue Engineering and Cellular Biology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices